ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK Gsk Plc

1,605.50
-161.00 (-9.11%)
Last Updated: 15:42:32
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -161.00 -9.11% 1,605.50 1,605.50 1,606.00 1,637.50 1,589.50 1,616.50 11,376,340 15:42:32
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.42 66.12B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,766.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,820.00p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £66.12 billion. Gsk has a price to earnings ratio (PE ratio) of 13.42.

Gsk Share Discussion Threads

Showing 32351 to 32374 of 33225 messages
Chat Pages: Latest  1305  1304  1303  1302  1301  1300  1299  1298  1297  1296  1295  1294  Older
DateSubjectAuthorDiscuss
05/7/2023
21:26
GSK shareprice below what it was 30 years ago. Astra ahead, something not right.
montyhedge
05/7/2023
20:52
I was willing to give her a chance but, yes, think she's had long enough now. Time for some fresh ideas
rikky72
05/7/2023
16:46
The token ceo is a dead loss-clueless. With treasury yields of 5%+ why buy this for a 4% divi (or even AZN). If she was any good-been there 5 yr+-the company would be paying 6% at least-that's why going nowhere fast.
cumnor
05/7/2023
16:19
Bought at 1370, sold at 1502, back in today when my limit order triggered at 1359 - all inside six months. Will it fall further? Your guess is as good as (probably better than) mine. At least GSK pays a dividend if it is long depressing wait !
poggy120
05/7/2023
16:07
When will this dog have its day *sigh*
rikky72
05/7/2023
07:57
Aspartame causing cancer..leave before too late
covid 19 deal
04/7/2023
11:11
But it is the vaccine (esp. COVID) makers that have fared the worst in the first half of 2023:

Pharmaceutical giant Pfizer (down 27%) is the worst-performing stock with a market capitalization over $200 billion due in part to a decline in Covid-19 vaccine sales; vaccine rival Moderna is similarly down 33%.

tradermichael
03/7/2023
17:55
Bad day for AZN. They still need to lose another 65% to equal GSKs market cap though!
rikky72
03/7/2023
14:48
Back of the ranch GSK is going for Red in sympathy
abdullla
03/7/2023
14:17
Abdulla, i don't think so. Gsk volume is still low for today.
hjs
03/7/2023
09:39
It looks that people are selling AZN and moving into GSK
abdullla
30/6/2023
21:11
Trading well in Dow
timothyo2
30/6/2023
09:02
Watching and agonising over these micro movements is never going to help you. Take a year away from the screen and come back to £18 (or £10, one never knows with GSK :)
rikky72
30/6/2023
08:52
10p up now almost down to zero
abdullla
29/6/2023
20:22
Who goes for a gnorreah vaccination ne?

Serious question?

deanowls
29/6/2023
19:45
Don't want to say this but I'm petrified of what would happen to the share price with bad news ! This is just a nonsense.
panache1
29/6/2023
16:20
Every time good news is published here we get bad results in the form of share price going down hill
abdullla
29/6/2023
14:45
ssued: 28 June 2023, London UK

GSK completes acquisition of BELLUS Health

GSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) today announced GSK has completed the acquisition of BELLUS, a biopharmaceutical company working to better the lives of patients suffering from refractory chronic cough (RCC), by way of a plan of arrangement in accordance with Section 192 of the Canada Business Corporations Act (the "Arrangement"). The Arrangement was approved by BELLUS' shareholders on 16 June 2023.

As previously announced, the acquisition of BELLUS includes camlipixant, a potential best-in-class and highly selective P2X3 antagonist currently in phase III development for the first-line treatment of adult patients with RCC.

In connection with the closing of the Arrangement, BELLUS also announced the cancellation of its annual shareholder meeting, which was scheduled for 30 June 2023.

Luke Miels, Chief Commercial Officer, GSK said: "The acquisition of BELLUS is highly synergistic with GSK's expertise in respiratory medicines and is further supported by GSK's leading R&D, manufacturing, and commercialisation capabilities. We are now focused on progressing camlipixant through phase III trials to offer a therapeutic option for RCC patients as soon as possible."

Following the anticipated regulatory approval and launch of camlipixant, the acquisition is expected to be accretive to adjusted EPS from 2027 and has the potential to deliver significant sales through 2031 and beyond.

tradermichael
29/6/2023
10:08
Since Covid-19 is a VERY transmissible disease as we all now have experienced

buywell posits that this thread title

Alzheimer's can be caught .... It's a transmissible disease

Is in fact now proven by the following


----------------- Long Covid = Long Term Problem ---------------------


The Cleveland Clinic in the US is a well renowned and respected institution

100 Years of Cleveland Clinic

Cleveland Clinic: A Centennial History

Cleveland Clinic was at the forefront of modern medicine when it was first organized as a multi-specialty group practice in 1921. From a small outpatient clinic, it has grown to become the world’s first integrated international health system. With more than 65,000 caregivers worldwide, Cleveland Clinic has almost 6 million patient visits per year, at more than 200 locations.


Regarding Oxygen Therapy the Cleveland Clinic state:

What is oxygen therapy?

Oxygen therapy helps people with lung diseases or breathing problems get the oxygen their bodies need to function.
This oxygen is supplemental (additional) to what you breathe in from the air.
You may also hear the term supplemental oxygen.


Who needs oxygen therapy?

You may need oxygen therapy if you have:

Asthma, bronchitis or emphysema.
Chronic obstructive pulmonary disease (COPD).
COVID-19.
Cystic fibrosis.
Heart failure.
Lung cancer or other cancers.
Pneumonia.
Pulmonary fibrosis.
Sleep apnea.


The Cleveland Clinic also state :

What are signs of low oxygen levels (hypoxia)?

You can’t always tell when your oxygen levels are low. When symptoms occur, you may experience:

Shortness of breath.
Bluish tint to skin, lips and nails.
Extreme fatigue.
Severe headaches.
Coughing or wheezing.
Fast pulse and heart rate.
Confusion.




buywell points out in recent posts the NHS state:

Home oxygen therapy can help with symptoms such as:

breathlessness
feeling tired all the time
memory problems
coughing



Note that ALL four in the NHS list above appear in the Cleveland Clinic list and ALL four are also symptoms of Long Covid

The US CDC goes further still stating:

Long Covid symptoms include

People with Long COVID may experience many symptoms.

People with Long COVID can have a wide range of symptoms that can last weeks, months, or even years after infection. Sometimes the symptoms can even go away and come back again. For some people, Long COVID can last weeks, months, or years after COVID-19 illness and can sometimes result in disability.

Long COVID may not affect everyone the same way. People with Long COVID may experience health problems from different types and combinations of symptoms happening over different lengths of time. Though most patients’ symptoms slowly improve with time, speaking with your healthcare provider about the symptoms you are experiencing after having COVID-19 could help determine if you might have Long COVID.

People who experience Long COVID most commonly report:

General symptoms (Not a Comprehensive List)

Tiredness or fatigue that interferes with daily life
Symptoms that get worse after physical or mental effort (also known as “post-exertional malaise”)
Fever
Respiratory and heart symptoms

Difficulty breathing or shortness of breath
Cough
Chest pain
Fast-beating or pounding heart (also known as heart palpitations)
Neurological symptoms

Difficulty thinking or concentrating (sometimes referred to as “brain fog”)
Headache
Sleep problems
Dizziness when you stand up (lightheadedness)
Pins-and-needles feelings
Change in smell or taste
Depression or anxiety
Digestive symptoms

Diarrhea
Stomach pain
Other symptoms

Joint or muscle pain
Rash
Changes in menstrual cycles


buywell concludes:

The WHO state that 36 Million people in the EU now suffer from Long Covid



The CDC state that around 20% of Americans acquiring Covid-19 develop Long Covid ie around 20 Million in the US.



IMO long term Home Oxygen Therapy will be a recognized treatment for Long Covid sufferers

When that happens the global market for oxygen concentrators will double --- and since new variants of Covid-19 continue --- so too does the number of long term sufferers with Long Covid.

This problem of Long Covid is NOT going away --- it is in fact getting worse

Increasing numbers of those that suffer this disease are now unable to work any more which also means long term unemployment issues are on the increase.

Worldwide -- Long Covid needs urgent government initiatives and solutions now

dyor


Addendum

Confusion, memory problems and loss of smell are all symptoms of Long Covid

Plaques in the brains of Covid-19 patients have recently been identified, such similar plaques have also been identified in the brains of people suffering from dementia

SARS-CoV-2, the virus that causes COVID-19, can produce short-term and long-term symptoms.
Researchers of a new study found that amyloids, the abnormal proteins that are also known to cause Alzheimer’s, could be formed during SARS-CoV-2 infection, which could explain some of the symptoms experienced.
The research suggests that the immune system’s interaction with SARS-CoV-2 may be leading to the production of these misfolded spike proteins, resulting in blood clots and neurological symptoms.

buywell3
28/6/2023
16:48
Every silver linings is killing the share price
abdullla
28/6/2023
13:46
That gonorrhoea vaccine should be a big money spinner for GSK, 82 million folks were infected with gonorrhoea last year globallly. And currently GSK has the only approved vaccine
igoe104
28/6/2023
13:40
GSK Q1 dividend pays in 2 weeks (Thursday 13 July). I will buy more shares at these prices with the payout.
tradermichael
27/6/2023
17:10
Market-wide malaise. Nothing GSK-specific to worry about right now. AIMO of course and touch wood!
Think markets are heading lower still, for a bit at least, so not tempted to add unless we lose circa a quid from the current share price Would rather see 15 quid first, so I can sell up though :) GLA.

lovewinshatelosses
27/6/2023
16:22
Could be sectoral as AZN down by similar amount today..
rikky72
Chat Pages: Latest  1305  1304  1303  1302  1301  1300  1299  1298  1297  1296  1295  1294  Older